FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss
Preprint in bioRxiv (May 2024)
The most recent citing publications are shown below. View all 54 publications that cite this research output on Dimensions.
Preprint in bioRxiv (May 2024)
Article in Journal of Drug Targeting (May 2024)
Preprint in bioRxiv (May 2024)